{"disease":{"id":"peyronies-disease","name":"peyronies disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07117955","title":"Platelet-Rich Plasma for Peyronie's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT07177833","title":"Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Ottawa Hospital Research Institute","has_results":false},{"nct_id":"NCT06789510","title":"Treatment of Peyronie's Disease With Platelet-Rich Plasma","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Herlev Hospital","has_results":false},{"nct_id":"NCT04326465","title":"Fractionated Carbon Dioxide Laser Therapy for Treatment of Peyronie's Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"University of British Columbia","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}